Molycorp (MCP) Sees Continued Insider Buying
Tweet
Share
E-mail
Get Alerts MCP Hot Sheet
Join SI Premium – FREE
Days after Molycorp (NYSE: MCP) CEO Mark Smith disclosed the purchase of 20,000 shares, two other insiders disclosed recent purchases.
Director Charles Henry bought 45,192 shares on 11/20 at $6.95-$7.10
VP John Ashburn bought 10,000 shares on 11/19 at $6.20
All the insider purchases come amid an SEC investigation that has sent shares reeling. On November 13th, Morgan Stanley downgraded the stock specifically because of the probe. The firm said that while the worst case scenario is already priced in, given the uncertainty surrounding this issue and the possibility that it will take some time to resolve they are stepping aside.
All the insider purchases come amid an SEC investigation that has sent shares reeling. On November 13th, Morgan Stanley downgraded the stock specifically because of the probe. The firm said that while the worst case scenario is already priced in, given the uncertainty surrounding this issue and the possibility that it will take some time to resolve they are stepping aside.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EMA validates Pfizer and Valneva's Lyme disease vaccine application
- Valvoline prices $600M senior notes offering, upsized from $500M
- GrabAGun names Jonathan Terry as CFO, replacing retiring co-founder
Create E-mail Alert Related Categories
Insider TradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
